Allergy and Infectious Diseases Research in New Jersey
Allergy and Infectious Diseases Research (93.855) awarded $394 million to recipients in New Jersey in 201 grants from fiscal 2021 to 2025, 1.8% of the program's national total. Rutgers the State University of New Jersey received the most, $175 million.
- Awarded in New Jersey$394 million
- Awards201
- Share of the program1.8%
- Rank among states14th of 52
- National total$22 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 95 | $65.9 million |
| FY 2022 | 90 | $129 million |
| FY 2023 | 80 | $62.6 million |
| FY 2024 | 85 | $56.6 million |
| FY 2025 | 97 | $80.0 million |
Recipients in New Jersey
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Rutgers the State University of New Jersey | Colleges and universities | 80 | $175 million |
| HMH Hospitals Corporation | Colleges and universities | 27 | $142 million |
| The Trustees of Princeton University | Colleges and universities | 20 | $20.7 million |
| Rutgers, the State University | Colleges and universities | 24 | $17.8 million |
| Prokaryotics Incorporated | Small businesses | 9 | $9.5 million |
| Rutgers, the State University | Colleges and universities | 13 | $9.1 million |
| Analytical Diagnostic Solutions Inc | Small businesses | 3 | $3.5 million |
| Novaflux Inc. | Small businesses | 1 | $3.0 million |
| Taxis Pharmaceuticals Inc | Small businesses | 2 | $2.8 million |
| Kathera Bioscience Inc | Small businesses | 3 | $2.2 million |
Open opportunities under this program
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- Immune Tolerance Network (UM1 Clinical Trial Required)
- Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
- NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)
- Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
See all 93 on the program page
Questions people ask
How much Allergy and Infectious Diseases Research money goes to New Jersey?
$394 million from fiscal 2021 to 2025, across 201 awards. New Jersey ranks 14th of 52 states and territories for this program.
Who receives Allergy and Infectious Diseases Research money in New Jersey?
The largest recipient is Rutgers the State University of New Jersey, with $175 million in 80 awards. Next are HMH Hospitals Corporation and The Trustees of Princeton University.
Can organizations in New Jersey apply now?
Yes, 93 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Allergy and Infectious Diseases Research in other states
Other large programs in New Jersey
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Children's Health Insurance Program
- Special Education Grants to States
- 1332 State Innovation Waivers
- Title I Grants to Local Educational Agencies